Arcadia Biosciences (RKDA) Enterprise Value (2016 - 2025)
Arcadia Biosciences (RKDA) has disclosed Enterprise Value for 12 consecutive years, with -$5.9 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Enterprise Value rose 12.65% year-over-year to -$5.9 million, compared with a TTM value of -$5.9 million through Sep 2025, up 12.65%, and an annual FY2024 reading of -$4.2 million, up 63.99% over the prior year.
- Enterprise Value was -$5.9 million for Q3 2025 at Arcadia Biosciences, down from -$4.4 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$3.2 million in Q1 2025 and bottomed at -$50.7 million in Q1 2021.
- Average Enterprise Value over 5 years is -$18.8 million, with a median of -$18.6 million recorded in 2023.
- The sharpest move saw Enterprise Value plummeted 4968.14% in 2021, then skyrocketed 63.99% in 2024.
- Year by year, Enterprise Value stood at -$28.6 million in 2021, then rose by 27.31% to -$20.8 million in 2022, then surged by 43.3% to -$11.8 million in 2023, then soared by 63.99% to -$4.2 million in 2024, then crashed by 38.26% to -$5.9 million in 2025.
- Business Quant data shows Enterprise Value for RKDA at -$5.9 million in Q3 2025, -$4.4 million in Q2 2025, and -$3.2 million in Q1 2025.